CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
- Update frequency
- every 3 days
- Average duration
- 25 minutes
- Episodes
- 461
- Years Active
- 2020 - 2025
Managing ART Failure: Answering the Questions
In this episode, Daniel R. Kuritzkes, MD, and Cristina Mussini, MD, discuss managing ART failure, including:
- The definitions of virologic blips, low-level viremia, and virologic failure on ART
- The infr…
Challenging Scenarios: Managing a First ART Failure
In this episode, Renslow Sherer, MD, discusses managing a first ART failure in the setting of COVID-19, including:
- Guideline recommendations for resistance testing
- Guideline recommendations for selecti…
PrEP Talks: Uptake in Racial and Ethnic Minority Men Who Have Sex With Men and Transgender Individuals
In this episode, Kenyon R. Farrow and Raphael J. Landovitz, MD, MSc, discuss key considerations to PrEP uptake in transgender individuals and racial and ethnic minority men who have sex with men, inc…
PrEP Initiation: Answering the Questions
In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, and Meredith Clement, MD, discuss PrEP initiation, including:
- The importance of taking a sexual history and getting to know your pa…
Viral Hepatitis Update: CCO Independent Conference Coverage of EASL 2023
In this episode, Stefan Zeuzem, MD, discusses new data on viral hepatitis presented at EASL 2023, including:
- Hepatitis B virus
- Durability of response with bepirovirsen
- HBsAg loss with siRNA VIR-2218 com…
Treatment of Skin and Soft Tissue Infections
In this episode, Kyle Molina, PharmD, BCIDP, provides an overview of treatment of skin and soft tissue infections (SSTIs) and challenges in practice. Listen as he gives perspectives on:
- Guideline reco…
Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley
In this episode, Latesha Elopre, MD, MSPH, and Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, answer questions about HIV PrEP including:
- How long someone can receive PrEP and the monitoring that …
Q&A on Barriers to HIV PrEP: Pharmacist Perspectives
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, and Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discuss key considerations to barriers to PrEP uptake, including:
- Limited data on…
Older Adults: Overcoming HBV Barriers
In this episode, Robert S. Brown, Jr., MD, MPH; Nancy Reau, MD; and Eric, a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in older adults, including:
- Aw…
Hepatitis Delta in Focus: Episode 4 of Answering the Questions on Screening, Diagnosis, and Treatment
In this episode, Tarik Asselah, MD, PhD, and Ira Jacobson, MD, provide expert insight on HDV screening, diagnosis, and management, including:
- Approach to screening
- Barriers to screening (eg, test avail…
Preparing for the Fall: New RSV Vaccine Approvals
In this episode, Helen Y. Chu, MD, MPH, shares updates on RSV vaccines, including:
- An overview of vaccine candidates under investigation
- Recently FDA-approved RSV vaccines for older adults
- Consideration…
Hepatitis Delta in Focus: Episode 3 of Answering the Questions on Screening, Diagnosis, and Treatment
In this episode, Nancy Reau, MD, and Heiner Wedemeyer, MD, provide expert insight on HDV management, including:
- Use of noninvasive imaging or biopsy for staging liver disease
- Screening for hepatocellul…
Modifying ART in the Presence of Hyperlipidemia: Using HIV-ASSIST
In this episode, Maunank Shah, MD, PhD, discusses using HIV-ASSIST to optimize treatment for both HIV and hyperlipidemia. Listen as he covers:
- Hyperlipidemia and cardiovascular disease risk among peop…
The Burden of Skin and Soft Tissue Infections: Epidemiology, Clinical Presentation, and Diagnosis
In this episode, Martin Krsak, MD, MSc, FASAM, provides background and context on skin and soft tissue infections. Listen as he gives perspectives on:
- Epidemiology and clinical outcomes
- Economic impact
- …
Choosing Between Initial ART Options: Answering the Questions
In this episode, Marta Boffito, MD, PhD, FRCP, and Michelle Cespedes, MD, MS, discuss initial ART options, including:
- Recommended first-line ART options for most PWH according to DHHS, IAS-USA, EACS, …
Choosing ART for HIV With HBV and HCV Coinfections: Using HIV-ASSIST
In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, discusses using HIV-ASSIST to aid in the selection of an ART regimen for PWH coinfected with HBV and HCV. Listen as she covers:
- How HIV-ASSIST sup…
Integrating New Data on LA ART From CROI 2023: Pharmacist Perspectives
In this episode, Amanda Binkley, PharmD, BCIDP, AAHIVP, and Nimish Patel, PharmD, PhD, AAHIVP, discuss clinically relevant data on long-acting ART from CROI 2023, including:
- LA CAB + RPV in San Franci…
Christine Katlama and Babafemi Taiwo: Answering the Questions on Optimizing Antiretroviral Therapy in Heavily Treatment–Experienced People With HIV
In this episode, Christine Katlama, MD, and Babafemi Taiwo, MBBS, discuss optimizing ART for people with HIV who are treatment experienced or failing a current ART regimen, including:
- Recycling agents…
Preconception ART Selection: Using HIV-ASSIST
In this episode, Sonya Krishnan, MD, MHS, discusses using HIV-ASSIST to aid in the selection of an ART regimen for a virologically suppressed PWH who is planning a pregnancy. Listen as she covers:
- How…
Long-Acting ART: Cabotegravir Plus Rilpivirine
In this episode, Ian Frank, MD, discusses long-acting HIV treatment with cabotegravir plus rilpivirine for people with HIV, including:
- Efficacy data with every-8-week dosing
- Real-world use in people wi…